Effects of prostaglandins B1 and B2 on vasoconstrictor responses of the canine hindpaw.
D000704:Analysis of Variance; D000818:Animals; D003650:Decamethonium Compounds / Q000494:pharmacology; D003714:Denervation; D004285:Dogs; D004558:Electric Stimulation; D005260:Female; D006614:Hindlimb / Q000098:blood supply; D007269:Injections, Intra-Arterial; D008297:Male; D009638:Norepinephrine / Q000008:administration & dosage / Q000494:pharmacology; D011453:Prostaglandins / Q000494:pharmacology*; D012039:Regional Blood Flow / Q000187:drug effects; D012584:Sciatic Nerve / Q000187:drug effects; D013564:Sympathetic Nervous System / Q000502:physiology; D013997:Time Factors; D014439:Tyramine / Q000008:administration & dosage / Q000494:pharmacology; D014655:Vascular Resistance / Q000187:drug effects; D014662:Vasoconstrictor Agents / Q000494:pharmacology*; D014666:Vasomotor System / Q000187:drug effects*
D003650:Decamethonium Compounds; D011453:Prostaglandins; D014662:Vasoconstrictor Agents; D009638:Norepinephrine; D014439:Tyramine